Mineralocorticoid receptor signalling in primary aldosteronism

J Endocrinol. 2023 Aug 28;259(1):e220249. doi: 10.1530/JOE-22-0249. Print 2023 Sep 1.

Abstract

Primary aldosteronism, or Conn syndrome, is the most common endocrine cause of hypertension. It is associated with a higher risk of cardiovascular, metabolic and renal diseases, as well as a lower quality of life than for hypertension due to other causes. The multi-systemic effects of primary aldosteronism can be attributed to aldosterone-mediated activation of the mineralocorticoid receptor in a range of tissues. In this review, we explore the signalling pathways of the mineralocorticoid receptor, with a shift from the traditional focus on the regulation of renal sodium-potassium exchange to a broader understanding of its role in the modulation of tissue inflammation, fibrosis and remodelling. The appreciation of primary aldosteronism as a multi-system disease with tissue-specific pathophysiology may lead to more vigilant testing and earlier institution of targeted interventions.

Keywords: adrenal cortex; aldosterone; cortisol; mineralocorticoid receptor; primary aldosteronism.

Publication types

  • Review

MeSH terms

  • Aldosterone / metabolism
  • Humans
  • Hyperaldosteronism* / complications
  • Hypertension* / complications
  • Mineralocorticoid Receptor Antagonists
  • Quality of Life
  • Receptors, Mineralocorticoid / metabolism

Substances

  • Receptors, Mineralocorticoid
  • Mineralocorticoid Receptor Antagonists
  • Aldosterone